FXR2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.329400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.354000E-01
Normal-vs-Stage2
6.528000E-01
Normal-vs-Stage3
1.036180E-01
Normal-vs-Stage4
6.839400E-01
Stage1-vs-Stage2
3.053200E-01
Stage1-vs-Stage3
1.987760E-01
Stage1-vs-Stage4
4.119200E-01
Stage2-vs-Stage3
2.394600E-01
Stage2-vs-Stage4
9.991400E-01
Stage3-vs-Stage4
3.661200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.524000E-01
Normal-vs-AfricanAmerican
8.470000E-01
Normal-vs-Asian
3.214000E-01
Caucasian-vs-AfricanAmerican
6.430200E-01
Caucasian-vs-Asian
1.248050E-01
AfricanAmerican-vs-Asian
1.448770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.684400E-01
Normal-vs-Female
9.921200E-01
Male-vs-Female
6.047000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.590600E-01
Normal-vs-Age(41-60Yrs)
7.206400E-01
Normal-vs-Age(61-80Yrs)
6.963000E-01
Normal-vs-Age(81-100Yrs)
6.048800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.514800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.855800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.868400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.776700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.832180E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.842000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.179600E-01
Normal-vs-Daily Drinker
6.884000E-01
Normal-vs-Weekly Drinker
8.906800E-01
Normal-vs-Occasional Drinker
5.964200E-01
Normal-vs-Social Drinker
6.052400E-01
Non Drinker-vs-Daily Drinker
7.366000E-01
Non Drinker-vs-Weekly Drinker
4.067000E-01
Non Drinker-vs-Occasional Drinker
1.773590E-01
Non Drinker-vs-Social Drinker
1.925780E-01
Daily Drinker-vs-Weekly Drinker
6.474800E-01
Daily Drinker-vs-Occasional Drinker
2.712000E-01
Daily Drinker-vs-Social Drinker
2.715200E-01
Weekly Drinker-vs-Occasional Drinker
5.473000E-01
Weekly Drinker-vs-Social Drinker
5.396800E-01
Occasional Drinker-vs-Social Drinker
9.945800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.144600E-01
Normal-vs-Grade 2
8.216800E-01
Normal-vs-Grade 3
8.379400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.162300E-02
Grade 1-vs-Grade 3
3.737900E-02
Grade 1-vs-Grade 4
9.144600E-01
Grade 2-vs-Grade 3
5.721600E-01
Grade 2-vs-Grade 4
8.216800E-01
Grade 3-vs-Grade 4
8.379400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.038400E-01
Normal-vs-NonDiabetic
9.448000E-01
Diabetic-vs-NonDiabetic
1.791400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.261600E-01
Normal-vs-NoPancreatitis
9.196600E-01
Pancreatitis-vs-NoPancreatitis
3.915600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.559000E-01
Normal-vs-N1
6.539200E-01
N0-vs-N1
4.343600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.623700E-02
Normal-vs-TP53-NonMutant
2.046200E-01
TP53-Mutant-vs-TP53-NonMutant
4.957100E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
